<Record>
<Term>Doxorubicin Preparation</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Anthracycline Antineoplastic Antibiotic</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Enzyme Inhibitor/Topoisomerase Inhibitor/Topoisomerase-II Inhibitor/Anthracycline Antineoplastic Antibiotic/Doxorubicin Preparation</ClassificationPath>
<BroaderTerm>Topoisomerase Inhibitor</BroaderTerm>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Enzyme Inhibitor</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>Topoisomerase-II Inhibitor</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<BroaderTerm>Doxorubicin Preparation</BroaderTerm>
<BroaderTerm>Anthracycline Antineoplastic Antibiotic</BroaderTerm>
<ChildTerm>Pegylated Liposomal Doxorubicin Hydrochloride</ChildTerm>
<ChildTerm>Doxorubicin-GNRH Agonist Conjugate AEZS-108</ChildTerm>
<ChildTerm>Doxorubicin-Magnetic Targeted Carrier Complex</ChildTerm>
<ChildTerm>PVA Microporous Hydrospheres:Doxorubicin Hydrochloride</ChildTerm>
<ChildTerm>Doxorubicin-HPMA Conjugate</ChildTerm>
<ChildTerm>Doxorubicin</ChildTerm>
<ChildTerm>Doxorubicin Hydrochloride</ChildTerm>
<ChildTerm>Lyso-Thermosensitive Liposome Doxorubicin</ChildTerm>
<ChildTerm>Liposome-Encapsulated Doxorubicin Citrate</ChildTerm>
<ChildTerm>Doxorubicin Prodrug INNO-206</ChildTerm>
<Synonym>Doxorubicin Preparation</Synonym>
<Source>NCI Thesaurus</Source>
</Record>
